Dimitris Agrafiotis

Dr. Agrafiotis is a Director of Digital, Analytics, and AI of Arsenal where he focuses on the development and deployment of advanced digital and technology solutions for our healthcare investment strategies and portfolio companies. He is a respected thought leader, a published scientist, and an accomplished software architect, with extensive experience in building teams to support pharmaceutical R&D in biotech, large pharma, and the biopharmaceutical services industry. In addition to working previously as an Arsenal Senior Advisor, Dr. Agrafiotis served as Chief Digital Officer for Generate Biomedicines, Vice President of Digital for Pfizer, Chief Information Officer for the Novartis Institutes for Biomedical Research, Chief Data Officer & Head of Technology Products of Covance/Labcorp, and Vice President of Research and Early Development Informatics and IT of Johnson & Johnson (J&J). Prior to J&J, he spent ten years at biotech startup 3-Dimensional Pharmaceuticals, from its founding to its IPO and eventual acquisition by J&J. He started his career as a Senior Scientist in the Computer-Aided Drug Design group at Parke-Davis, which he joined following postdoctoral fellowships. He is the recipient of numerous awards and distinctions, including being elected Fellow of the Royal Society of Chemistry and named in Computerworld’s Premier 100 Technology Leaders.